<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>TriGemX Bio raises $94M Series A+ led by undisclosed investors.</p><p>Participants include a mix of venture capital firms and strategic partners.</p><p>TriGemX Bio develops medicines for the treatment of migraine. The company is led by CEO Johnny Smith.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>TriGemX Bio</td></tr><tr><th>Amount</th><td>$94M</td></tr><tr><th>Sectors</th><td>biotechnology</td></tr></tbody></table>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>TriGemX Bio raises <strong>$94M</strong> Series A+ led by undisclosed investors.</p>
<p>Participants include a mix of <a href="/company/venture/">venture</a> capital firms and strategic partners.</p>
<p>TriGemX Bio develops medicines for the treatment of migraine. The company is led by CEO Johnny Smith.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>TriGemX Bio</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$94M</strong></td>
</tr>
<tr>
<th>Sectors</th>
<td>biotechnology</td>
</tr>
</tbody></table>
</div>


Trigemx Bio Raises $94M

Trigemx Bio Raises $94M | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>TriGemX Bio raises <strong>$94M</strong> Series A+ led by undisclosed investors.</p>
<p>Participants include a mix of <a href="/company/venture/">venture</a> capital firms and strategic partners.</p>
<p>TriGemX Bio develops medicines for the treatment of migraine. The company is led by CEO Johnny Smith.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>TriGemX Bio</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$94M</strong></td>
</tr>
<tr>
<th>Sectors</th>
<td>biotechnology</td>
</tr>
</tbody></table>
</div>

Trigemx Bio Raises $94M

ABOUT THIS STORY

Asi Raises $325M at $3B Valuation

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared

Company	TriGemX Bio
Amount	$94M
Sectors	biotechnology

Trigemx Bio Raises $94M

ABOUT THIS STORY

More articles

Asi Raises $325M at $3B Valuation

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared